Millennium Management’s Avanos Medical AVNS Stock Holding History

Millennium Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40,000	Closed	-$1.46M	–	6768
2021 Q2	$1.46M	Buy	40,000 +20,000	+100%	+$827K	﹤0.01%	4297
2021 Q1	$875K	Buy	+20,000	New	+$939K	﹤0.01%	4343
2020 Q4	–	Sell	-10,000	Closed	-$332	–	5183
2020 Q3	$332	Buy	+10,000	New	+$320K	﹤0.01%	3786
2020 Q1	–	Sell	-20,000	Closed	-$674K	–	3826
2019 Q4	$674K	Buy	+20,000	New	+$724K	﹤0.01%	3197
2019 Q3	–	Sell	-10,000	Closed	-$436K	–	4150
2019 Q2	$436K	Sell	10,000 -140,000	-93%	-$5.99M	﹤0.01%	3326
2019 Q1	$6.4M	Buy	150,000 +50,000	+50%	+$2.24M	0.01%	1586
2018 Q4	$4.48M	Buy	100,000 +50,000	+100%	+$2.62M	0.01%	1663
2018 Q3	$3.42M	Hold	50,000	–	–	﹤0.01%	2063
2018 Q2	$2.86M	Buy	+50,000	New	+$2.64M	﹤0.01%	2166
2017 Q1	–	Sell	-125,000	Closed	-$4.62M	–	3473
2016 Q4	$4.62M	Buy	+125,000	New	+$4.47M	0.01%	1374

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Millennium Management's AVNS Position: Q1 2026 in Review

Millennium Management reduced its Avanos Medical (AVNS) stake by 98% in Q1 2026, selling an estimated $9.67M and leaving 13,826 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #5198.

Millennium Management first reported a position in AVNS in Q4 2014 and has held it in 43 quarters since. The position peaked at $29.3M in Q2 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Millennium Management held 13,826 shares of Avanos Medical worth $194K as of Q1 2026.
Millennium Management sold 718,074 Avanos Medical shares in Q1 2026, an estimated $9.67M.
Avanos Medical made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5198 holding.
Millennium Management first reported a position in Avanos Medical in Q4 2014 and has held it in 43 quarters since.
Millennium Management's Avanos Medical position peaked at $29.3M in Q2 2018.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.